Financial Information

SEC Filings

Filing date	Form	Description	Filing Group	View
Sep 01, 2023	6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	Current Reports	0001213900-23-073206.pdf 0001213900-23-073206.rtf 0001213900-23-073206.xls View HTML
Sep 01, 2023	6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	Current Reports	0001213900-23-073215.pdf 0001213900-23-073215.rtf 0001213900-23-073215.xls View HTML
Aug 09, 2023	6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	Current Reports	0001213900-23-064758.pdf 0001213900-23-064758.rtf 0001213900-23-064758.xls View HTML
Aug 09, 2023	6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	Current Reports	0001213900-23-065007.pdf 0001213900-23-065007.rtf 0001213900-23-065007.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
Jun 22, 2023	6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	Current Reports	0001213900-23-050715.pdf 0001213900-23-050715.rtf 0001213900-23-050715.xls View HTML
Jun 05, 2023	6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	Current Reports	0001213900-23-046181.pdf 0001213900-23-046181.rtf 0001213900-23-046181.xls View HTML
May 22, 2023	6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	Current Reports	0001213900-23-041749.pdf 0001213900-23-041749.rtf 0001213900-23-041749.xls View HTML
May 19, 2023	424B5	Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3	Registration Statements	0001213900-23-041506.pdf 0001213900-23-041506.rtf View HTML
May 17, 2023	SC 13G/A	An amendment to the SC 13G filing	Other	0001178913-23-001929.pdf 0001178913-23-001929.rtf 0001178913-23-001929.xls View HTML
May 10, 2023	6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	Current Reports	0001213900-23-037874.pdf 0001213900-23-037874.rtf 0001213900-23-037874.xls View HTML

Data provided by Kaleidoscope.

Technology

PolyPid’s PLEX targeted drug delivery platform enables localized, controlled, continuous release of medication over prolonged periods of time for better patient outcomes.

D-PLEX₁₀₀

Provides safe and effective local antibiotic protection against SSI (surgical Site Infection) at the needed tissues or organs by administration during surgical procedures.

D-PLEX₁₀₀₀

Comprised of antibiotic eluting ß tri-calcium phosphate (ßTCP) granules, designed for bone related infections applications.